Physician profile
Bret B Abshire
NPI 1992741912
$2,329,115.73
in general payments reported to CMS, 2019-2025
10 companies · $479K in 2025
The $479K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242K · 2020: $314K · 2021: $350K · 2022: $323K · 2023: $258K · 2024: $363K · 2025: $479K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.1M · Consulting Fee: $17K · Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,083,159.75 |
| Consulting Fee | $16,875.00 |
| Food and Beverage | $367.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $2,328,580.69 | 2019-2025 | Identiti, Trestle Luxe II, Other - Miscellaneous |
| Orthofix Medical, INC. | $144.53 | 2021 | |
| Melinta Therapeutics, LLC | $117.01 | 2019 | |
| Heron Therapeutics, INC. | $82.60 | 2020 | |
| Stryker Corporation | $42.23 | 2021 | |
| Ethicon US, LLC | $40.99 | 2022-2023 | Echelon Endopath, Surgiflo Hemostatic Matrix, Echelon Flex |
| Medtronic, INC. | $34.42 | 2022 | |
| Integra Lifesciences Corporation | $34.23 | 2021-2025 | Codman Certas, Codman Hakim, Cusa Clarity |
| Abbvie INC. | $19.59 | 2022 | |
| Providence Medical Technology, INC. | $19.44 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Abshire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.